Learn
A little clarity for your next decision.
Loading your learning library…
Investor WorkspaceWelcome, there!Log Out
Investor WorkspaceA little clarity for your next decision.
By Jerry Baker
HPA Exchange, branded online as HPA Xchange, invests in healthcare real estate through DSTs and other private structures. This guide explains its medical property focus, management roles, and the lease, tenant, building, and tax questions I would review before considering an investment.
The company's website terms identify HPA Exchange, LLC, and a Brea, California, address. The HPA Xchange branding refers to that platform; it should not be confused with unrelated companies using the letters HPA. I would match the complete legal name on each offering document. [1]
HPA's current team page lists Robert Lee as co-president and chief investment officer and Thùy Turner as co-president and chief operating officer. It says HPA Exchange is a joint venture. The partners are Vital Capital Partners and The Innovation Institute. Turner also holds an operating role at the affiliated Healthcare Property Advisors business. [2]
Those relationships help explain the platform. They do not establish that every affiliated company guarantees a property's rent or an investor's capital. I would ask for an entity chart. It should show the issuer, manager, owner, and any related tenant or service firm.
This profile covers public information and questions for further review. It does not confirm an available offering through Baker 1031, a sponsor relationship, or a completed private investment review.
HPA describes a focus on ambulatory medical properties and selected life science and behavioral health assets. Its website discusses both single-tenant and multitenant buildings, with health systems and physician groups among its target tenants. These are the firm's stated areas of focus, not a guarantee of tenant strength or property performance. [3]
I would avoid treating healthcare as one uniform asset class. A building leased to several physician practices has a different risk pattern from a specialty treatment facility leased to one operator. A life science space may have different equipment, power, and tenant improvement needs.
Even two medical office buildings can differ sharply. One may be next to a major hospital and serve established practices. Another may depend on one growing provider with limited operating history. The tenant mix, lease terms, access, and cost to replace a tenant matter more than the label alone.
How does demand for care become rent at this address? A broad need for medical care is only the beginning of that analysis.
HPA's team descriptions separate investment strategy from operations. Lee's role includes acquisitions, dispositions, capital formation, and structuring. Turner's includes asset and property management, leasing, and financial underwriting. I would use those descriptions to identify responsibility, then verify the actual service agreements. [2]
A useful review would show who negotiates leases, approves capital spending, selects contractors, monitors tenant credit, and decides when to sell. If different affiliates perform those tasks, I want to understand how they report to the investment's manager.
I would also ask how the team handles a tenant problem. Who receives notice of missed rent? Who reviews a request to reduce space or change a guarantee? Who approves a workout, and what rights does the lender have?
Healthcare buildings may need specialized experience, but titles alone do not prove execution. I would request examples of comparable completed work and ask which current team members handled it. The relevant record is the record of the people and systems that will serve the proposed investment.
I would begin with the legal tenant. Is it a physician practice, a health system subsidiary, a hospital, a research company, or another operating business? The sign outside may use a brand that differs from the entity signing the lease.
Next, who stands behind the lease? Is there a parent guarantee? Is it full, limited, temporary, or subject to conditions? A tenant's relationship with a large health system does not automatically make the system responsible for the rent.
I would read the financial statements and rent payment record. I would ask where the tenant earns its money and how it funds its work. For a practice, I would ask about the providers on whom revenue depends and what happens when a key provider leaves. For a larger system, I would examine the particular entity and any support agreement.
These are proposed review questions, not claims that HPA's tenants have credit problems. The goal is to connect a familiar name with a written duty and the means to pay.
A healthcare building needs a review of both the service and the people it serves. Where do patients come from? What other facilities serve them? Who refers them? Why did the tenant choose this site? A broad demographic trend cannot answer whether one site has an advantage.
Access matters. I would check parking, patient drop-off, and any public transit. Can patients find the building? Is the route from nearby medical facilities easy to use? A building can be close on a map while being difficult for patients to reach.
I would also ask how much the tenant depends on referrals from one hospital or provider group. If that relationship changes, can the business replace the volume? Is the property useful to other tenants offering similar services?
For a site described as important to an operator, I want evidence of that importance. It might include a long lease, substantial tenant investment, a limited choice of alternate sites, or operational links to nearby facilities. None of those factors creates a guarantee. They help explain the tenant's incentive to stay.
A net lease label can hide meaningful differences. I would identify who pays taxes, insurance, maintenance, building systems, and major replacements. Some costs may remain with the landlord despite a broad description of tenant responsibility.
I would check rent increases and renewal options. I would also read rights to end, assign, or sublease the space, and remedies for default. I would also examine any provisions tied to licensing, use restrictions, or the tenant's ability to operate a particular service.
Tenant improvements deserve special attention. A medical suite may contain work that is valuable to one user but expensive to adapt for another. I would separate improvements paid by the landlord from those funded by the tenant and review what stays with the building.
A long lease helps with planning. It does not remove the risk of missed rent. A contractual rent increase has value only if the tenant can pay it. I would test the cost of vacancy, reconfiguration, and leasing before assuming that a long term makes the building easy to finance or sell.
I would ask experts to review the medical building and its systems. The file should include engineering, environmental, roof, mechanical, and life-safety reports suited to the asset. The exact scope should reflect the current use and the tenant's needs. A standard office checklist may miss specialized systems.
The review should fit the use. It may need to cover power, airflow, plumbing, backup systems, loading, waste, and patient access. I would ask experts which rules apply. I would not assume one set of rules covers every kind of medical building.
I would also ask how a future tenant could use the space. Can suites be divided? Can the building support a different medical use? Are there restrictions on signage, parking, or hours? A specialized property may be valuable to its current tenant but costly to re-lease.
Capital planning should follow the building's actual condition. If a major system is near the end of its useful life, the budget should show who pays and when. An attractive initial yield can be misleading if the investment will soon need a large repair.
HPA identifies selected life science and behavioral health assets within its focus. I would treat those as separate review assignments, not simply apply medical office assumptions. [3]
For a life science tenant, I would ask whether rent depends on operating revenue, research funding, investor funding, or support from a larger organization. A company with promising work may still face a funding gap. The landlord needs to understand the tenant's resources and lease duties without pretending to evaluate the science.
The building review may need to consider lab improvements, mechanical systems, specialized equipment, and the cost of returning space to a usable condition. I would ask which costs belong to the tenant and which could fall back on the owner.
For behavioral health, I would examine the operator's finances and required approvals. Does the building fit the use? What is the plan if service stops? This is a real estate review, not an assessment of clinical care. The relevant question is how operational interruptions could affect rent, use, and the cost of finding a replacement tenant.
A portfolio can contain several addresses while still relying on one health system or physician group. I would measure exposure in several ways: rent, value, tenant, guarantor, and market. I would also check when leases expire. Building count alone can create a false sense of variety.
Suppose a hypothetical portfolio has ten properties. One tenant occupies four and provides 55% of total rent. The portfolio has ten locations but a large single-tenant exposure. A change in that tenant's business could affect several properties at once.
I would also examine shared demand. Different tenants may depend on the same hospital, payer contracts, or local employer base. Those links do not mean diversification has failed, but they should be visible.
The same idea applies to lease expirations. Five buildings with leases ending in the same year may create a large combined leasing need. I would request a schedule showing when capital and income risks might arrive together rather than rely on an average lease term.
I would start with rent due and rent collected. Then I would subtract costs, debt payments, capital work, fees, and reserves. Each step should be clear. If the trust uses an affiliated master lease, I would also review the master tenant and the source of its payments.
Consider a hypothetical medical property collecting $1 million a year. If nonrecoverable expenses and reserves total $200,000, $800,000 remains before debt service. With $500,000 of annual debt service, $300,000 remains before other investment costs. If collected rent falls by $150,000 while those costs stay unchanged, the remaining amount falls to $150,000.
This example is not an HPA forecast. It shows how a 15% rent decline can cut that residual cash in half. I would test credit losses, capital work, and interest rates rather than assume all contractual rent arrives on time.
The debt file should include maturity, extension conditions, recourse, covenants, and any interest-rate protection. A long tenant lease does not automatically mean a long mortgage. The investment needs a plan for a loan coming due before a favorable sale is available.
HPA's focus page discusses DST ownership, possible 721 structures, joint ventures, and funds. It also describes intended hold periods and possible future choices. I would treat those statements as a description of the platform's goals and review the actual investor rights in each offering. [3]
The IRS recognized qualifying exchange treatment for a DST under the facts in Revenue Ruling 2004-86. That does not mean every trust or healthcare investment qualifies. Your tax adviser and qualified intermediary should review the structure, ownership, and exchange requirements. [5]
A contribution to a partnership under Section 721 has separate rules and exceptions. Debt, cash received, and other terms can affect the tax result. A possible future contribution should not be described as guaranteed or assumed to be an investor-controlled election without reading the documents. [6]
What you own after that step matters too. Partnership interests generally do not qualify as like-kind real property for a later 1031 exchange. I would make that change in future options part of the initial discussion. [7]
HPA's website terms discuss the possibility of overlapping management duties and interests in other entities. That is a reason to request clear disclosures for an investment, not proof that any particular conflict has caused harm. [1]
I would identify each affiliate that may receive money from the investment. The review should cover fees to buy, finance, manage, lease, build, and sell. Each may have a different payee or trigger. The fee basis matters as much as the percentage.
If a property moves between affiliated vehicles, I would ask who represents each side and how price is established. If an affiliated party holds an option to buy the property, I would review the option's timing, pricing formula, and effect on investor choice.
I would also request a sample report showing property results and cash sources. A regular distribution does not prove the property earned it. Reserves, borrowing, or other sources may affect how much capital remains and how long payments can continue.
HPA names American Alternative Capital as the firm through which it offers securities. It states that the two businesses are independent. That disclosure does not establish Baker 1031's participation in an offering. I would verify the actual parties and approvals for any transaction. [4]
The same disclosures warn of loss and lack of liquidity. They also discuss financing, market, and tax risks. Healthcare use does not remove those risks. It changes which questions deserve the most attention. [4]
I would compare the proposed income source with what you already own. Several healthcare investments may share tenants or regional risks. A new sponsor name does not always mean a new kind of risk.
I would finish with the investment's fit: required equity, allocated debt, expected cash, holding period, and available choices if circumstances change. I want to know why this real estate belongs in your plan. A broad interest in healthcare is not enough.
The website uses HPA Xchange branding and identifies HPA Exchange, LLC, in its terms. Match the full legal issuer and manager names in an actual offering. The initials alone are not enough to identify an investment or an affiliate. [1]
No. Review the legal tenant and any written guarantee. A brand connection, referral relationship, or nearby hospital does not by itself create a payment obligation. The lease and guarantee define which entity is responsible and under what conditions.
No. Its public focus includes ambulatory medical properties and selected life science and behavioral health assets. Those uses can require different tenant, building, and operating reviews. Do not assume they share the same risks or costs. [3]
Not necessarily. The specific documents determine who can elect or approve a transaction. HPA's general discussion of potential paths is not enough to establish your rights. Review choice, valuation, tax effects, and future liquidity before investing.
Yes. Tenant default, expenses, repairs, debt, and changes in market value can affect the investment. A lease is a contractual obligation, not insurance against loss. HPA's own disclosures include potential loss of principal and illiquidity. [4]
Start with the offering memorandum, entity chart, leases and guarantees, tenant financial information, building reports, debt terms, and fee schedule. Then compare the actual risks and rights with your exchange and income needs. This profile does not confirm current availability or recommend an offering.
Educational information, not an offer or a personal tax, legal, or investment recommendation. Examples are hypothetical and omit stated adjustments. Tax treatment depends on your facts and current law. Review your transaction with your CPA, attorney, and qualified intermediary. Real estate investments can lose value and may be illiquid.
Enter your approved email to explore investments, save your shortlist, and keep learning.